| Year |
Citation |
Score |
| 2023 |
Orhan F, Goiny M, Becklén M, Mathé L, Piehl F, Schwieler L, Fatouros-Bergman H, Farde L, Cervenka S, Sellgren CM, Engberg G, Erhardt S. CSF dopamine is elevated in first-episode psychosis and associates to symptom severity and cognitive performance. Schizophrenia Research. 257: 34-40. PMID 37271040 DOI: 10.1016/j.schres.2023.05.012 |
0.466 |
|
| 2023 |
Jangard S, Jayaram-Lindström N, Isacsson NH, Matheson GJ, Plavén-Sigray P, Franck J, Borg J, Farde L, Cervenka S. Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers. Addiction (Abingdon, England). PMID 36710462 DOI: 10.1111/add.16144 |
0.463 |
|
| 2021 |
Plavén-Sigray P, Ikonen Victorsson P, Santillo A, Matheson GJ, Lee M, Collste K, Fatouros-Bergman H, Sellgren CM, Erhardt S, Agartz I, Halldin C, Farde L, Cervenka S. Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis. Molecular Psychiatry. PMID 34759359 DOI: 10.1038/s41380-021-01349-x |
0.527 |
|
| 2021 |
Lee M, Fatouros-Bergman H, Plavén-Sigray P, Ikonen Victorsson P, Sellgren CM, Erhardt S, Flyckt L, Farde L, Cervenka S. No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis. Npj Schizophrenia. 7: 46. PMID 34548499 DOI: 10.1038/s41537-021-00176-x |
0.53 |
|
| 2020 |
Freiburghaus T, Svensson JE, Matheson GJ, Plavén-Sigray P, Lundberg J, Farde L, Cervenka S. Low convergent validity of [C]raclopride binding in extrastriatal brain regions: a PET study of within-subject correlations with [C]FLB 457. Neuroimage. 117523. PMID 33144221 DOI: 10.1016/j.neuroimage.2020.117523 |
0.539 |
|
| 2020 |
Tønnesen S, Kaufmann T, de Lange AG, Richard G, Doan NT, Alnæs D, van der Meer D, Rokicki J, Moberget T, Maximov II, Agartz I, Aminoff SR, Beck D, Barch DM, Beresniewicz J, ... Cervenka S, et al. Brain Age Prediction Reveals Aberrant Brain White Matter in Schizophrenia and Bipolar Disorder: A Multisample Diffusion Tensor Imaging Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32859549 DOI: 10.1016/J.Bpsc.2020.06.014 |
0.336 |
|
| 2020 |
Kerstens VS, Fazio P, Sundgren M, Matheson GJ, Franzén E, Halldin C, Cervenka S, Svenningsson P, Varrone A. Reliability of dopamine transporter PET measurements with [F]FE-PE2I in patients with Parkinson's disease. Ejnmmi Research. 10: 95. PMID 32797307 DOI: 10.1186/S13550-020-00676-4 |
0.327 |
|
| 2020 |
Elvsåshagen T, Bahrami S, van der Meer D, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Beyer MK, Blasi G, Borgwardt S, Boye B, Buitelaar J, Bøen E, Celius EG, ... Cervenka S, et al. The genetic architecture of human brainstem structures and their involvement in common brain disorders. Nature Communications. 11: 4016. PMID 32782260 DOI: 10.1038/S41467-020-17376-1 |
0.328 |
|
| 2020 |
Laurell GL, Plavén-Sigray P, Jucaite A, Varrone A, Cosgrove KP, Svarer C, Knudsen GM, Ogden RT, Zanderigo F, Cervenka S, Hillmer AT, Schain M. Non-displaceable binding is a potential confounding factor in CPBR28 TSPO PET studies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32680926 DOI: 10.2967/Jnumed.120.243717 |
0.408 |
|
| 2020 |
Tjerkaski J, Cervenka S, Farde L, Matheson GJ. Kinfitr - an open-source tool for reproducible PET modelling: validation and evaluation of test-retest reliability. Ejnmmi Research. 10: 77. PMID 32642865 DOI: 10.1186/s13550-020-00664-8 |
0.503 |
|
| 2020 |
Matheson GJ, Plavén-Sigray P, Louzolo A, Borg J, Farde L, Petrovic P, Cervenka S. Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness. Schizophrenia Research. PMID 32616361 DOI: 10.1016/J.Schres.2020.06.001 |
0.586 |
|
| 2020 |
Xu C, Sellgren CM, Fatouros-Bergman H, Piehl F, Blennow K, Zetterberg H, Brinkmalm A, Santillo AF, Lundgren S, Cervenka S, Engberg G, Erhardt S. CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects. Ibro Reports. 8: 136-142. PMID 32490278 DOI: 10.1016/j.ibror.2020.04.001 |
0.301 |
|
| 2020 |
Krasikova R, Kondrashov M, Avagliano C, Petukhov M, Vázquez-Romero A, Revunov E, Johnström P, Tari L, Toth M, Häggkvist J, Erhardt S, Cervenka S, Schou M. Synthesis and preclinical evaluation of 6-[18F]Fluorine-Alpha-Methyl-L-Tryptophan, a novel PET tracer for measuring tryptophan uptake. Acs Chemical Neuroscience. PMID 32343551 DOI: 10.1021/acschemneuro.0c00135 |
0.496 |
|
| 2020 |
Victorsson P, Plavén-Sigray P, Matheson G, Santillo A, Lee M, Collste K, Fatouros-Bergman H, Agartz I, Halldin C, Farde L, Cervenka S. M7. LOWER THALAMIC DOPAMINE D2-RECEPTOR BINDING IN DRUG-NAIVE PATIENTS WITH PSYCHOSIS – A REPLICATION STUDY USING POSITRON EMISSION TOMOGRAPHY Schizophrenia Bulletin. 46: S135-S136. DOI: 10.1093/Schbul/Sbaa030.319 |
0.617 |
|
| 2020 |
Plavén-Sigray P, Matheson G, Coughlin J, Hafizi S, Laurikainen H, Ottoy J, de’Picker L, Rusjan P, Hietala J, Howes O, Mizrahi R, Morrens M, Pomper M, Cervenka S. T7. UPDATED INDIVIDUAL PARTICIPANT DATA META-ANALYSIS CONFIRMS LOWER LEVELS OF THE GLIAL MARKER TSPO IN PSYCHOSIS PATIENTS Schizophrenia Bulletin. 46: S233-S233. DOI: 10.1093/Schbul/Sbaa029.567 |
0.377 |
|
| 2019 |
Kaufmann T, van der Meer D, Doan NT, Schwarz E, Lund MJ, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Bettella F, Beyer MK, Bøen E, Borgwardt S, Brandt CL, ... ... Cervenka S, et al. Publisher Correction: Common brain disorders are associated with heritable patterns of apparent aging of the brain. Nature Neuroscience. PMID 31848485 DOI: 10.1038/S41593-019-0553-6 |
0.311 |
|
| 2019 |
Svensson JE, Schain M, Plavén-Sigray P, Cervenka S, Tiger M, Nord M, Halldin C, Farde L, Lundberg J. In response to the letter "[C]raclopride and extrastriatal binding to D2/3 receptors". Neuroimage. 116371. PMID 31756518 DOI: 10.1016/J.Neuroimage.2019.116371 |
0.547 |
|
| 2019 |
Matheson GJ, Plavén-Sigray P, Tuisku J, Rinne J, Matuskey D, Cervenka S. Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31713656 DOI: 10.1007/s00259-019-04541-y |
0.313 |
|
| 2019 |
Svensson JE, Schain M, Plavén-Sigray P, Cervenka S, Tiger M, Nord M, Halldin C, Farde L, Lundberg J. Validity and reliability of extrastriatal [C]raclopride binding quantification in the living human brain. Neuroimage. 116143. PMID 31473354 DOI: 10.1016/J.Neuroimage.2019.116143 |
0.578 |
|
| 2019 |
Tuisku J, Plavén-Sigray P, Gaiser EC, Airas L, Al-Abdulrasul H, Brück A, Carson RE, Chen MK, Cosgrove KP, Ekblad L, Esterlis I, Farde L, Forsberg A, Halldin C, Helin S, ... ... Cervenka S, et al. Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [C]PBR28 HRRT PET study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31363804 DOI: 10.1007/S00259-019-04403-7 |
0.508 |
|
| 2019 |
Forsberg A, Lampa J, Estelius J, Cervenka S, Farde L, Halldin C, Lekander M, Olgart Höglund C, Kosek E. Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [C]PBR28 positron emission tomography. Journal of Neuroimmunology. 334: 577000. PMID 31260948 DOI: 10.1016/J.Jneuroim.2019.577000 |
0.51 |
|
| 2019 |
Alnæs D, Kaufmann T, van der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, Bettella F, Agartz I, Barch DM, Bertolino A, Brandt CL, Cervenka S, Djurovic S, Doan NT, Eisenacher S, et al. Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk. Jama Psychiatry. PMID 30969333 DOI: 10.1001/jamapsychiatry.2019.0257 |
0.325 |
|
| 2019 |
Stenkrona P, Matheson GJ, Halldin C, Cervenka S, Farde L. D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients. The International Journal of Neuropsychopharmacology. PMID 30958880 DOI: 10.1093/Ijnp/Pyz017 |
0.599 |
|
| 2019 |
Schwarz E, Doan NT, Pergola G, Westlye LT, Kaufmann T, Wolfers T, Brecheisen R, Quarto T, Ing AJ, Carlo PD, Gurholt TP, Harms RL, Noirhomme Q, Moberget T, Agartz I, ... ... Cervenka S, et al. Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder. Translational Psychiatry. 9: 12. PMID 30664633 DOI: 10.1038/S41398-018-0225-4 |
0.335 |
|
| 2018 |
Caravaggio F, Plavén-Sigray P, Matheson GJ, Plitman E, Chakravarty MM, Borg J, Graff-Guerrero A, Cervenka S. Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men. Plos One. 13: e0209584. PMID 30571791 DOI: 10.1371/journal.pone.0209584 |
0.335 |
|
| 2018 |
Plaven-Sigray P, Schain M, Zanderigo F, Rabiner I, Gunn R, Ogden T, Cervenka S. Accuracy and reliability of [11C]PBR28 specific binding estimated without the use of a reference region. Neuroimage. PMID 30500425 DOI: 10.1016/J.Neuroimage.2018.11.020 |
0.349 |
|
| 2018 |
Plavén-Sigray P, Matheson GJ, Cselényi Z, Jucaite A, Farde L, Cervenka S. Test-retest reliability and convergent validity of (R)-[C]PK11195 outcome measures without arterial input function. Ejnmmi Research. 8: 102. PMID 30498919 DOI: 10.1186/s13550-018-0455-8 |
0.717 |
|
| 2018 |
Griffioen G, Matheson GJ, Cervenka S, Farde L, Borg J. Serotonin 5-HT receptor binding and self-transcendence in healthy control subjects-a replication study using Bayesian hypothesis testing. Peerj. 6: e5790. PMID 30479884 DOI: 10.7717/peerj.5790 |
0.525 |
|
| 2018 |
Albrecht DS, Forsberg A, Sandstrom A, Bergan C, Kadetoff D, Protsenko E, Lampa J, Lee YC, Höglund CO, Catana C, Cervenka S, Akeju O, Lekander M, Cohen G, Halldin C, et al. Brain glial activation in fibromyalgia - a multi-site positron emission tomography investigation. Brain, Behavior, and Immunity. PMID 30223011 DOI: 10.1016/J.Bbi.2018.09.018 |
0.434 |
|
| 2018 |
Orhan F, Schwieler L, Fatouros-Bergman H, Malmqvist A, Cervenka S, Collste K, Flyckt L, Farde L, Sellgren CM, Piehl F, Engberg G, Erhardt S. Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis. Acta Psychiatrica Scandinavica. 138: 432-440. PMID 30132802 DOI: 10.1111/acps.12944 |
0.381 |
|
| 2018 |
Stenkrona P, Matheson GJ, Cervenka S, Sigray PP, Halldin C, Farde L. [C]SCH23390 binding to the D-dopamine receptor in the human brain-a comparison of manual and automated methods for image analysis. Ejnmmi Research. 8: 74. PMID 30069645 DOI: 10.1186/S13550-018-0416-2 |
0.62 |
|
| 2018 |
Plavén-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD, Mizrahi R, Pomper MG, Rusjan P, Veronese M, Wang Y, Cervenka S. Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data. Biological Psychiatry. PMID 29653835 DOI: 10.1016/J.Biopsych.2018.02.1171 |
0.38 |
|
| 2018 |
Plavén-Sigray P, Matheson GJ, Gustavsson P, Stenkrona P, Halldin C, Farde L, Cervenka S. Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study. Plos One. 13: e0193770. PMID 29543812 DOI: 10.1371/Journal.Pone.0193770 |
0.583 |
|
| 2018 |
Cervenka S. PET radioligands for the dopamine D1-receptor: Application in psychiatric disorders. Neuroscience Letters. PMID 29518542 DOI: 10.1016/j.neulet.2018.03.007 |
0.449 |
|
| 2018 |
Farde L, Plavén-Sigray P, Borg J, Cervenka S. Brain neuroreceptor density and personality traits: towards dimensional biomarkers for psychiatric disorders. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 373. PMID 29483342 DOI: 10.1098/rstb.2017.0156 |
0.512 |
|
| 2017 |
Tamm S, Cervenka S, Forsberg A, Estelius J, Grunewald J, Gyllfors P, Karshikoff B, Kosek E, Lampa J, Lensmar C, Strand V, Åkerstedt T, Halldin C, Ingvar M, Höglund CO, et al. Evidence of fatigue, disordered sleep and peripheral inflammation, but not increased brain TSPO expression, in seasonal allergy: A [(11)C]PBR28 PET study. Brain, Behavior, and Immunity. PMID 29054675 DOI: 10.1016/J.Bbi.2017.10.013 |
0.312 |
|
| 2017 |
Matheson GJ, Plavén-Sigray P, Forsberg A, Varrone A, Farde L, Cervenka S. Assessment of simplified ratio-based approaches for quantification of PET [(11)C]PBR28 data. Ejnmmi Research. 7: 58. PMID 28733954 DOI: 10.1186/S13550-017-0304-1 |
0.539 |
|
| 2017 |
Jayaram-Lindström N, Guterstam J, Häggkvist J, Ericson M, Malmlöf T, Schilström B, Halldin C, Cervenka S, Saijo T, Nordström AL, Franck J. Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study. Translational Psychiatry. 7: e1104. PMID 28440810 DOI: 10.1038/Tp.2017.79 |
0.357 |
|
| 2017 |
Matheson GJ, Stenkrona P, Cselényi Z, Plavén-Sigray P, Halldin C, Farde L, Cervenka S. Reliability of Volumetric and Surface-Based Normalisation and Smoothing Techniques for PET Analysis of the Cortex: A Test-Retest Analysis using [(11)C]SCH-23390. Neuroimage. PMID 28419852 DOI: 10.1016/J.Neuroimage.2017.04.031 |
0.727 |
|
| 2017 |
Plavén-Sigray P, Hedman E, Victorsson P, Matheson GJ, Forsberg A, Djurfeldt DR, Rück C, Halldin C, Lindefors N, Cervenka S. Extrastriatal dopamine D2-receptor availability in social anxiety disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 28377075 DOI: 10.1016/J.Euroneuro.2017.03.007 |
0.474 |
|
| 2017 |
Hall B, Mak E, Cervenka S, Aigbirhio FI, Rowe JB, O'Brien JT. in vivo tau PET imaging in dementia: pathophysiology, radiotracer quantification, and a systematic review of clinical findings. Ageing Research Reviews. PMID 28315409 DOI: 10.1016/J.Arr.2017.03.002 |
0.301 |
|
| 2017 |
Forsberg A, Cervenka S, Jonsson Fagerlund M, Rasmussen LS, Zetterberg H, Erlandsson Harris H, Stridh P, Christensson E, Granström A, Schening A, Dymmel K, Knave N, Terrando N, Maze M, Borg J, et al. The immune response of the human brain to abdominal surgery. Annals of Neurology. PMID 28253549 DOI: 10.1002/Ana.24909 |
0.497 |
|
| 2017 |
Collste K, Plavén-Sigray P, Fatouros-Bergman H, Victorsson P, Schain M, Forsberg A, Amini N, Aeinehband S, Erhardt S, Halldin C, Flyckt L, Farde L, Cervenka S. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [(11)C]PBR28. Molecular Psychiatry. PMID 28194003 DOI: 10.1038/mp.2016.247 |
0.521 |
|
| 2017 |
Collste K, Orhan F, Erhardt S, Schwieler L, Flyckt L, Farde L, Engberg G, Cervenka S. Associations between central chemokine levels and glial activation in first episode psychosis – a positron emission tomography study European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31329-9 |
0.487 |
|
| 2017 |
Lekander M, Tamm S, Cervenka S, Forsberg A, Lensmar C, Kosek E, Lampa J, Estelius J, Karshikoff B, Ingvar M, Olgart Höglund C. Seasonal variation in central and peripheral inflammation in allergic subjects: A PET study Brain, Behavior, and Immunity. 66: e34. DOI: 10.1016/j.bbi.2017.07.125 |
0.367 |
|
| 2017 |
Doef TFvd, Doorduin J, Berckel BNMv, Cervenka S. Erratum to : Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein (Clinical and Translational Imaging, (2015), 3, 6, (449-460), 10.1007/s40336-015-0140-0) Clinical and Translational Imaging. 5. DOI: 10.1007/S40336-017-0233-Z |
0.322 |
|
| 2016 |
Kanegawa N, Collste K, Forsberg A, Schain M, Arakawa R, Jucaite A, Lekander M, Höglund CO, Kosek E, Lampa J, Halldin C, Farde L, Varrone A, Cervenka S. In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects. Brain, Behavior, and Immunity. PMID 26820224 DOI: 10.1016/J.Bbi.2016.01.019 |
0.545 |
|
| 2016 |
Kanegawa N, Collste K, Forsberg A, Schain M, Arakawa R, Jucaite A, Lekander M, Höglund CO, Kosek E, Lampa J, Halldin C, Farde L, Varrone A, Cervenka S. Abstract # 1847 Cross-sectional and longitudinal associations between immune cells in blood and brain – A TSPO PET study in healthy control subjects Brain, Behavior, and Immunity. 57: e38. DOI: 10.1016/J.Bbi.2016.07.127 |
0.551 |
|
| 2015 |
van der Doef TF, Doorduin J, van Berckel BNM, Cervenka S. Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein. Clinical and Translational Imaging. 3: 449-460. PMID 28781965 DOI: 10.1007/s40336-015-0140-0 |
0.36 |
|
| 2015 |
Borg J, Cervenka S, Kuja-Halkola R, Matheson GJ, Jönsson EG, Lichtenstein P, Henningsson S, Ichimiya T, Larsson H, Stenkrona P, Halldin C, Farde L. Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain. Molecular Psychiatry. PMID 26821979 DOI: 10.1038/Mp.2015.147 |
0.61 |
|
| 2015 |
Collste K, Forsberg A, Varrone A, Amini N, Aeinehband S, Yakushev I, Halldin C, Farde L, Cervenka S. Test-retest reproducibility of [(11)C]PBR28 binding to TSPO in healthy control subjects. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26293827 DOI: 10.1007/S00259-015-3149-8 |
0.56 |
|
| 2015 |
Matheson GJ, Schain M, Almeida R, Lundberg J, Cselényi Z, Borg J, Varrone A, Farde L, Cervenka S. Diurnal and seasonal variation of the brain serotonin system in healthy male subjects. Neuroimage. 112: 225-31. PMID 25772667 DOI: 10.1016/J.Neuroimage.2015.03.007 |
0.727 |
|
| 2014 |
Plavén-Sigray P, Gustavsson P, Farde L, Borg J, Stenkrona P, Nyberg L, Bäckman L, Cervenka S. Dopamine D1 receptor availability is related to social behavior: a positron emission tomography study. Neuroimage. 102: 590-5. PMID 25134976 DOI: 10.1016/J.Neuroimage.2014.08.018 |
0.564 |
|
| 2014 |
Fatouros-Bergman H, Cervenka S, Flyckt L, Edman G, Farde L. Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia. Schizophrenia Research. 158: 156-62. PMID 25086658 DOI: 10.1016/j.schres.2014.06.034 |
0.468 |
|
| 2013 |
de Manzano Ö, Cervenka S, Jucaite A, Hellenäs O, Farde L, Ullén F. Individual differences in the proneness to have flow experiences are linked to dopamine D2-receptor availability in the dorsal striatum. Neuroimage. 67: 1-6. PMID 23128075 DOI: 10.1016/J.Neuroimage.2012.10.072 |
0.534 |
|
| 2013 |
Guterstam J, Jayaram-Lindström N, Cervenka S, Frost JJ, Farde L, Halldin C, Franck J. Effects of amphetamine on the human brain opioid system--a positron emission tomography study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 763-9. PMID 22932428 DOI: 10.1017/S1461145712000818 |
0.538 |
|
| 2012 |
Cervenka S, Hedman E, Ikoma Y, Djurfeldt DR, Rück C, Halldin C, Lindefors N. Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder. Translational Psychiatry. 2: e120. PMID 22832965 DOI: 10.1038/Tp.2012.40 |
0.475 |
|
| 2012 |
Comley RA, Cervenka S, Palhagen SE, Panagiotidis G, Matthews JC, Lai RY, Halldin C, Farde L, Nichols TE, Whitcher BJ. A comparison of gray matter density in restless legs syndrome patients and matched controls using voxel-based morphometry. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 22: 28-32. PMID 21091816 DOI: 10.1111/J.1552-6569.2010.00536.X |
0.511 |
|
| 2012 |
Guterstam J, Jayaram-Lindstrom N, Cervenka S, Halldin C, Farde L, Frost J, Franck J. P.3.004 Amphetamine-opioid interactions in the human brain reward system – a PET study using [11C]carfentanil European Neuropsychopharmacology. 22: S55. DOI: 10.1016/S0924-977X(12)70057-3 |
0.522 |
|
| 2010 |
de Manzano O, Cervenka S, Karabanov A, Farde L, Ullén F. Thinking outside a less intact box: thalamic dopamine D2 receptor densities are negatively related to psychometric creativity in healthy individuals. Plos One. 5: e10670. PMID 20498850 DOI: 10.1371/Journal.Pone.0010670 |
0.596 |
|
| 2010 |
Karabanov A, Cervenka S, de Manzano O, Forssberg H, Farde L, Ullén F. Dopamine D2 receptor density in the limbic striatum is related to implicit but not explicit movement sequence learning. Proceedings of the National Academy of Sciences of the United States of America. 107: 7574-9. PMID 20368439 DOI: 10.1073/Pnas.0911805107 |
0.487 |
|
| 2010 |
Cervenka S, Varrone A, Fransén E, Halldin C, Farde L. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans. Synapse (New York, N.Y.). 64: 478-85. PMID 20175222 DOI: 10.1002/Syn.20765 |
0.63 |
|
| 2010 |
Cervenka S, Gustavsson JP, Halldin C, Farde L. Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability. Neuroimage. 50: 323-8. PMID 20004254 DOI: 10.1016/J.Neuroimage.2009.12.006 |
0.586 |
|
| 2009 |
MacDonald SW, Cervenka S, Farde L, Nyberg L, Bäckman L. Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning. Neuropsychologia. 47: 2299-304. PMID 19524093 DOI: 10.1016/J.Neuropsychologia.2009.01.016 |
0.577 |
|
| 2009 |
Cervenka S, Halldin C, Farde L. P.1.06 Limbic dopamine D2-receptor binding and social desirability European Neuropsychopharmacology. 19: S7-S8. DOI: 10.1016/S0924-977X(09)70009-4 |
0.551 |
|
| 2008 |
Cervenka S, Bäckman L, Cselényi Z, Halldin C, Farde L. Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum. Neuroimage. 40: 1287-95. PMID 18296072 DOI: 10.1016/J.Neuroimage.2007.12.063 |
0.593 |
|
| 2008 |
Cervenka S, Halldin C, Farde L. Age-related diurnal effect on D2 receptor binding: a preliminary PET study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 11: 671-8. PMID 18184446 DOI: 10.1017/S1461145707008358 |
0.607 |
|
| 2006 |
Cervenka S, Pålhagen SE, Comley RA, Panagiotidis G, Cselényi Z, Matthews JC, Lai RY, Halldin C, Farde L. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain : a Journal of Neurology. 129: 2017-28. PMID 16816393 DOI: 10.1093/Brain/Awl163 |
0.627 |
|
| 2006 |
Sovago J, Farde L, Cervenka S, Halldin C, Gulyas B. Increasing the accuracy of in vivo quantification of dopamine-D2/D3 receptor binding in the human brain by partial volume effect correction Neuroimage. 31: T85. DOI: 10.1016/J.Neuroimage.2006.04.073 |
0.771 |
|
| 2004 |
Talvik M, Nordström AL, Larsen NE, Jucaite A, Cervenka S, Halldin C, Farde L. A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration. Psychopharmacology. 175: 148-53. PMID 15007534 DOI: 10.1007/S00213-004-1802-1 |
0.541 |
|
| Show low-probability matches. |